Skip to content

Elastic Compression in Chronic Venous Disease

Randomised Trial Comparing the Effectiveness of Elastic Compression in Treating Chronic Venous Disease (CEAP C2-C5)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02641600
Acronym
RECVEN
Enrollment
30
Registered
2015-12-29
Start date
2015-12-31
Completion date
2017-04-30
Last updated
2016-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicosity

Brief summary

Patients with chronic venous disease causing pain or ache will be randomised into two groups, active stockings (18-21 mmHg) or placebo stockings

Detailed description

Patients with chronic venous disease causing pain or ache satisfying the inclusion and exclusion criteria will be randomised into two groups, active stockings (18-21 mmHg) or placebo stockings. The primary outcome of the study (pain/ache scored using a visual analogue scale) and a number of secondary symptoms, signs and rVCSS (revised Venous Clinical Severity Score) will be obtained at baseline and after one week of wearing the active or placebo stocking.

Interventions

Use of elastic stockings to alleviate patient symptoms

DEVICEPlacebo stockings

Placebo stocking with pressure applied to the legs

Sponsors

University of Patras
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Primary varicose veins causing pain/ache located only at the calf level

Exclusion criteria

* Venous ulceration * Dermatitis * Itching * Superficial vein thrombosis * Peripheral arterial disease * Symptoms of non-venous origin * Previous use of elastic stockings

Design outcomes

Primary

MeasureTime frameDescription
Pain/ache assessed using a visual analogue scale (0-10)One weekPatients with varicose veins often complain for dull pain of ache. This will be assessed using a visual analogue scale (0-10)

Secondary

MeasureTime frameDescription
Heaviness assessed using a visual analogue scale (0-10)One weekPatients with varicose veins often complain for heaviness. This will be assessed using a visual analogue scale (0-10)
Night cramps assessed using a visual analogue scale (0-10)One weekPatients with varicose veins often complain for night cramps. These will be assessed using a visual analogue scale (0-10)
Swelling sensation assessed using a visual analogue scale (0-10)One weekPatients with varicose veins often complain for sensation of swelling. This will be assessed using a visual analogue scale (0-10)
Burning sensation assessed using a visual analogue scale (0-10)One weekPatients with varicose veins often complain for burning sensation. This will be assessed using a visual analogue scale (0-10)
revised Venous Clinical Severity Score (rVCSS)One weekrevised Venous Clinical Severity Score
Restless legs assessed using a visual analogue scale (0-10)One weekPatients with varicose veins often complain for restless legs. This symptom will be assessed using a visual analogue scale (0-10)
throbbing assessed using a visual analogue scale (0-10)One weekPatients with varicose veins often complain for throbbing of their varicose veins. This will be assessed using a visual analogue scale (0-10)
insomnia assessed using a visual analogue scale (0-10)One weekPatients with varicose veins often complain for insomnia. This will be assessed using a visual analogue scale (0-10)
Ankle circumferenceOne weekThis will be measured just above the malleoli, at the smallest point.
Paresthesia assessed using a visual analogue scale (0-10)One weekPatients with varicose veins often complain for paresthesia. This will be assessed using a visual analogue scale (0-10)

Countries

Greece

Contacts

Primary ContactStavros K Kakkos, MD, PhD, RVT
kakkos@upatras.gr302613603406

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026